Bloomberg BNA's Randy Kubetin on Life Sciences Patents


Bloomberg BNA's Randy Kubetin discusses new study on recent U.S. Supreme Court decisions that have had far-reaching impact on the multibillion dollar global life sciences industry, making it more difficult for companies to obtain patents.